Elevance Health, Inc.
ELV
$547.71
$3.820.70%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 144.59B | 144.68B | 143.03B | 141.37B | 137.82B |
| Total Other Revenue | 27.16B | 26.66B | 25.60B | 24.34B | 22.85B |
| Total Revenue | 171.75B | 171.34B | 168.63B | 165.72B | 160.68B |
| Cost of Revenue | 124.09B | 124.33B | 123.19B | 122.01B | 119.20B |
| Gross Profit | 47.66B | 47.01B | 45.44B | 43.71B | 41.48B |
| SG&A Expenses | 35.94B | 35.51B | 34.99B | 33.55B | 31.75B |
| Depreciation & Amortization | 766.00M | 885.00M | 915.00M | 928.00M | 873.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 160.79B | 160.72B | 159.09B | 156.49B | 151.82B |
| Operating Income | 10.95B | 10.62B | 9.53B | 9.23B | 8.86B |
| Income Before Tax | 8.04B | 7.72B | 7.76B | 8.23B | 7.91B |
| Income Tax Expenses | 1.80B | 1.72B | 1.72B | 1.90B | 1.80B |
| Earnings from Continuing Operations | 6.24K | 5.99K | 6.04K | 6.34K | 6.11K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 8.00M | -4.00M | -41.00M | -25.00M | -19.00M |
| Net Income | 6.24B | 5.99B | 6.00B | 6.31B | 6.09B |
| EBIT | 10.95B | 10.62B | 9.53B | 9.23B | 8.86B |
| EBITDA | 12.57B | 12.36B | 11.33B | 11.05B | 10.64B |
| EPS Basic | 26.59 | 25.31 | 25.27 | 26.48 | 25.45 |
| Normalized Basic EPS | 26.39 | 25.34 | 22.31 | 21.59 | 20.68 |
| EPS Diluted | 26.46 | 25.17 | 25.13 | 26.30 | 25.24 |
| Normalized Diluted EPS | 26.28 | 25.21 | 22.18 | 21.44 | 20.50 |
| Average Basic Shares Outstanding | 940.40M | 945.20M | 950.60M | 954.90M | 959.00M |
| Average Diluted Shares Outstanding | 944.30M | 949.80M | 955.20M | 960.90M | 966.50M |
| Dividend Per Share | 6.07 | 5.92 | 5.72 | 5.52 | 5.32 |
| Payout Ratio | 22.79% | 23.30% | 22.58% | 20.79% | 20.86% |
